Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on December 29, 2004

Arteriosclerosis, Thrombosis, and Vascular Biology. 2004
Published online before print December 29, 2004, doi: 10.1161/01.ATV.0000154489.53077.4e
A more recent version of this article appeared on March 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/3/622    most recent
01.ATV.0000154489.53077.4ev1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, Y.
Right arrow Articles by Kodama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, Y.
Right arrow Articles by Kodama, T.

Submitted on August 11, 2004
Accepted on November 24, 2004

Expression of the LXR{alpha} Protein in Human Atherosclerotic Lesions

Yuichiro Watanabe ; Shuying Jiang ; Wakako Takabe ; Riuko Ohashi ; Toshiya Tanaka ; Yasutoshi Uchiyama ; Keiko Katsumi ; Hiroko Iwanari ; Noriko Noguchi ; Makoto Naito ; Takao Hamakubo ; and Tatsuhiko Kodama *

From the Department of Systems Biology and Medicine (Y.W., W.T., T.T., N.N., T.H., T.K.), Research Center for Advanced Science and Technology, the University of Tokyo; the Immunology Research Department (Y.W.), Tokyo New Drug Research Laboratories II, Pharmaceutical Division, Kowa Co Ltd; Perseus Proteomics Inc (S.J., Y.U., K.K., H.I.), Tokyo; and the Department of Cellular Function (S.J., R.O., M.N.), Division of Cellular and Molecular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

* To whom correspondence should be addressed. E-mail: kodama{at}lsbm.org.

Objective--Liver X-activated receptor {alpha} (LXR{alpha}) regulates multiple genes controlling cholesterol metabolism and transport. To clarify its role in atherogenesis, we established a monoclonal antibody recognizing native human LXR{alpha} protein and studied the expression pattern in human atherosclerotic lesions.

Methods and Results--A novel monoclonal antibody PPZ0412 was raised against the ligand-binding domain of LXR{alpha}, which can be used for immunostaining of human LXR{alpha} protein. LXR{alpha} protein was detected in the nucleus of macrophages in the liver, spleen, or lung and also in hepatocytes and adipocytes. In atherosclerotic lesions, the LXR{alpha} protein was detected in macrophages positive for scavenger receptor class A and/or CD68.

Conclusions--In the human body, the LXR{alpha} protein is highly expressed in macrophage lineage cells and foam cells in atherosclerotic lesions and is identified as a target for intervention in atherosclerotic disease.


Key words: LXR{alpha} • atherosclerosis • macrophages • monoclonal antibody




This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
A. Sakamoto, T. Kawasaki, T. Kazawa, R. Ohashi, S. Jiang, T. Maejima, T. Tanaka, H. Iwanari, T. Hamakubo, J. Sakai, et al.
Expression of Liver X Receptor {alpha} in Rat Fetal Tissues at Different Developmental Stages
J. Histochem. Cytochem., June 1, 2007; 55(6): 641 - 649.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Ito, S.-i. Funahashi, N. Yamauchi, J. Shibahara, Y. Midorikawa, S. Kawai, Y. Kinoshita, A. Watanabe, Y. Hippo, T. Ohtomo, et al.
Identification of ROBO1 as a Novel Hepatocellular Carcinoma Antigen and a Potential Therapeutic and Diagnostic Target.
Clin. Cancer Res., June 1, 2006; 12(11): 3257 - 3264.
[Abstract] [Full Text] [PDF]